HCRT and insomnia measurement: Compared with traditional benzodiazepines and non-benzodiazepine drugs, DORAs inhibit the hyperactive arousal pathway in patients with insomnia by blocking orexin function (Beuckmann et al., 2017; Xue et al., 2023).